miR-122-5p Regulates Renal Fibrosis In Vivo

Shohei Kaneko1, Katsunori Yanai1, Hiroki Ishii1

  • 1Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama 330-8503, Japan.

Insights

MicroRNAs (miRNAs) impact kidney fibrosis. Downregulated miR-122-5p exacerbates renal fibrosis by upregulating pro-fibrotic genes, while its inhibition protects against kidney fibrosis.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Genetics

Background:

  • The role of exogenous microRNAs (miRNAs) in renal fibrosis remains largely unknown.
  • Renal fibrosis is a significant pathological process contributing to chronic kidney disease progression.

Purpose of the Study:

  • To investigate the effect of exogenous microRNAs on renal fibrosis.
  • To elucidate the specific role of miR-122-5p in the pathogenesis of renal fibrosis.

Main Methods:

  • A unilateral ureteral obstruction (UUO) mouse model was utilized to induce renal fibrosis.
  • miRNA microarray analysis and quantitative reverse-transcription polymerase chain reaction (qRT-PCR) were performed.
  • The effects of miR-122-5p mimic and inhibitor on fibrosis markers and target gene expression were assessed.

Main Results:

  • miR-122-5p was significantly downregulated in the kidneys of UUO mice.
  • Overexpression of miR-122-5p promoted renal fibrosis and upregulated collagen type I alpha 2 chain (COL1A2) and fibronectin 1 (FN1).
  • Inhibition of miR-122-5p suppressed renal fibrosis and downregulated COL1A2 and FN1, while upregulating anti-fibrotic FOXO3 and its downstream target LC3.

Conclusions:

  • miR-122-5p plays a critical role in regulating renal fibrosis.
  • Modulating miR-122-5p levels offers a potential therapeutic strategy for kidney fibrosis.

Related Concept Videos